Updated review of the existing maximum residue levels for imazalil according to Article 12 of Regulation (EC) No 396/2005 following new toxicological information

In compliance with Article 43 of Regulation (EC) No 396/2005, EFSA received a mandate from the European Commission to provide an update of the reasoned opinion on the review of existing maximum residue levels (MRLs) for imazalil published on 5 September 2017, taking into account the additional infor...

Descripción completa

Detalles Bibliográficos
Autores principales: Brancato, Alba, Brocca, Daniela, Carrasco Cabrera, Luis, De Lentdecker, Chloe, Erdos, Zoltan, Ferreira, Lucien, Greco, Luna, Jarrah, Samira, Kardassi, Dimitra, Leuschner, Renata, Lostia, Alfonso, Lythgo, Christopher, Medina, Paula, Miron, Ileana, Molnar, Tunde, Pedersen, Ragnor, Reich, Hermine, Sacchi, Angela, Santos, Miguel, Stanek, Alois, Sturma, Juergen, Tarazona, Jose, Theobald, Anne, Vagenende, Benedicte, Villamar‐Bouza, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Reasoned Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009713/
https://www.ncbi.nlm.nih.gov/pubmed/32625729
http://dx.doi.org/10.2903/j.efsa.2018.5453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009713/
https://www.ncbi.nlm.nih.gov/pubmed/32625729
http://dx.doi.org/10.2903/j.efsa.2018.5453

Ejemplares similares